The DOI matches its Crossref record; 264 of the 264 references it cites were found in a registry or an index.
Progress in understanding and controlling respiratory syncytial virus: Still crazy after all these years
Open accessAbstract
Human respiratory syncytial virus (RSV) is a ubiquitous pathogen that infects everyone worldwide early in life and is a leading cause of severe lower respiratory tract disease in the pediatric population as well as in the elderly and in profoundly immunosuppressed individuals. RSV is an enveloped, nonsegmented negative-sense RNA virus that is classified in Family Paramyxoviridae and is one of its more complex members. Although the replicative cycle of RSV follows the general pattern of the Paramyxoviridae, it encodes additional proteins. Two of these (NS1 and NS2) inhibit the host type I and type III interferon (IFN) responses, among other functions, and another gene encodes two novel RNA synthesis factors (M2-1 and M2-2). The attachment (G) glycoprotein also exhibits unusual features, such as high sequence variability, extensive glycosylation, cytokine mimicry, and a shed form that helps the virus evade neutralizing antibodies. RSV is notable for being able to efficiently infect early in life, with the peak of hospitalization at 2–3 months of age. It also is notable for the ability to reinfect symptomatically throughout life without need for significant antigenic change, although immunity from prior infection reduces disease. It is widely thought that re-infection is due to an ability of RSV to inhibit or subvert the host immune response. Mechanisms of viral pathogenesis remain controversial. RSV is notable for a historic, tragic pediatric vaccine failure involving a formalin-inactivated virus preparation that was evaluated in the 1960’s and that was poorly protective and paradoxically primed for enhanced RSV disease. RSV also is notable for the development of a successful strategy for passive immunoprophylaxis of high-risk infants using RSV-neutralizing antibodies. Vaccines and new antiviral drugs are in pre-clinical and clinical development, but controlling RSV remains a formidable challenge.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Items 201–264 of 264
Roymans, D., Bondt, H. L. D., Arnoult, É., Geluykens, P., Gevers, T., Ginderen, M. V., Verheyen, N., Kim, H., Willebrords, R., Bonfanti, J., et al. (2009) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0910108106 · Cited by 95
Gan, S. W., Ng, L., Lin, X., Gong, X., & Torres, J. (2008) · Protein Science · doi:10.1110/ps.073366208 · Cited by 95
Collarini, E. J., Lee, F. E.-H., Foord, O., Park, M., Sperinde, G. V., Wu, H., Harriman, W. D., Carroll, S. F., Ellsworth, S. L., Anderson, L. J., et al. (2009) · The Journal of Immunology · doi:10.4049/jimmunol.0901373 · Cited by 95
Growth of Respiratory Syncytial Virus in Primary Epithelial Cells from the Human Respiratory Tract
Wright, P. F., Ikizler, M. R., Gonzales, R. A., Carroll, K. N., Johnson, J. E., & Werkhaven, J. A. (2005) · Journal of Virology · doi:10.1128/jvi.79.13.8651-8654.2005 · Cited by 93
Respiratory syncytial virus bronchiolitis: Disease severity, interleukin‐8, and virus genotype*
Smyth, R. L., Mobbs, K. J., O'Hea, U., Ashby, D., & Hart, C. A. (2002) · Pediatric Pulmonology · doi:10.1002/ppul.10080 · Cited by 93
Paradiso, P. R., Hildreth, S. W., HOGERMAN, D. A., et al. (1994) · The Pediatric Infectious Disease Journal · doi:10.1097/00006454-199409000-00008 · Cited by 93
Shinoff, J. J., O’Brien, K. L., Thumar, B., Shaw, J., Reid, R., Hua, W., Santosham, M., & Karron, R. A. (2008) · The Journal of Infectious Diseases · doi:10.1086/591460 · Cited by 93
Surfactant protein C-deficient mice are susceptible to respiratory syncytial virus infection
Glasser, S. W., Witt, T. L., Senft, A. P., Baatz, J. E., Folger, D., Maxfield, M. D., Akinbi, H. T., Newton, D. A., Prows, D. R., & Korfhagen, T. R. (2009) · American Journal of Physiology-Lung Cellular and Molecular Physiology · doi:10.1152/ajplung.90640.2008 · Cited by 91
Takeuchi, K., Komatsu, T., Kitagawa, Y., Sada, K., & Gotoh, B. (2008) · Journal of Virology · doi:10.1128/jvi.00599-08 · Cited by 89
Whitehead, S. S., Juhász, K., Firestone, C.-Y., Collins, P. L., & Murphy, B. R. (1998) · Journal of Virology · doi:10.1128/jvi.72.5.4467-4471.1998 · Cited by 88
Self-citationCollins, P. L., Olmsted, R. A., Spriggs, M. K., Johnson, P. R., & Buckler-White, A. J. (1987) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.84.15.5134 · Cited by 87
Self-citationSchmidt, A. C., Wenzke, D. R., McAuliffe, J. M., Claire, M. S., Elkins, W. R., Murphy, B. R., & Collins, P. L. (2002) · Journal of Virology · doi:10.1128/jvi.76.3.1089-1099.2002 · Cited by 87
Self-citationBelshe, R. B., Anderson, E. L., & Walsh, E. E. (1993) · The Journal of Infectious Diseases · doi:10.1093/infdis/168.4.1024 · Cited by 85
Perez, M., García‐Barreno, B., Melero, J. A., Carrasco, L., & Guinea, R. (1997) · Virology · doi:10.1006/viro.1997.8696 · Cited by 84
Self-citationCarter, S. D., Dent, K. C., Atkins, E., Foster, T. L., Verow, M., Gorny, P., Harris, M., Hiscox, J. A., Ranson, N. A., Griffin, S. D. C., et al. (2010) · FEBS Letters · doi:10.1016/j.febslet.2010.05.006 · Cited by 83
Falsey, A. R., Walsh, E. E., Capellan, J., Gravenstein, S., Zambon, M. C. F. A., Yau, E., Gorse, G. J., Edelman, R., Hayden, F. G., McElhaney, J. E., et al. (2008) · The Journal of Infectious Diseases · doi:10.1086/592168 · Cited by 81
González, I. M., Karron, R. A., Eichelberger, M. C., Walsh, E. E., DeLaGarza, V. W., Bennett, R., Chanock, R. M., Murphy, B. R., Clements‐Mann, M. L., & Falsey, A. R. (2000) · Vaccine · doi:10.1016/s0264-410x(99)00527-7 · Cited by 79
Buchholz, U. J., Granzow, H., Schuldt, K., Whitehead, S. S., Murphy, B. R., & Collins, P. L. (2000) · Journal of Virology · doi:10.1128/jvi.74.3.1187-1199.2000 · Cited by 78
Self-citationMartin, E. T., Kuypers, J. M., Heugel, J., & Englund, J. A. (2008) · Diagnostic Microbiology and Infectious Disease · doi:10.1016/j.diagmicrobio.2008.08.002 · Cited by 75
Whitehead, S. S., Firestone, C.-Y., Collins, P. L., & Murphy, B. R. (1998) · Virology · doi:10.1006/viro.1998.9248 · Cited by 74
Self-citationEconomic impact of viral respiratory disease in children
Meissner, H. C. (1994) · The Journal of Pediatrics · doi:10.1016/s0022-3476(94)70186-5 · Cited by 73
Reed, J. L., Brewah, Y. A., Delaney, T. A., Welliver, T. P., Burwell, T. J., Benjamin, E., Kuta, E. G., Kozhich, A., McKinney, L., Suzich, J., et al. (2008) · The Journal of Infectious Diseases · doi:10.1086/593173 · Cited by 73
Kanra, G., Marchisio, P., Feiterna‐Sperling, C., Gaedicke, G., Lazar, H., Durrer, P., Kürsteiner, O., Herzog, C., Kara, A., & Principi, N. (2004) · The Pediatric Infectious Disease Journal · doi:10.1097/00006454-200404000-00005 · Cited by 72
Rodriguez, W. J., Hall, C. B., Welliver, C., Simões, E. A. F., Ryan, M. E., Stutman, H. R., Johnson, G. D., Dyke, R. V., Groothuis, J. R., Arrobio, J. O., et al. (1994) · The Journal of Pediatrics · doi:10.1016/s0022-3476(94)70139-3 · Cited by 72
Schlender, J., Walliser, G., Fricke, J., & Conzelmann, K. (2002) · Journal of Virology · doi:10.1128/jvi.76.3.1163-1170.2002 · Cited by 71
Hanley, L. L., McGivern, D. R., Teng, M. N., Djang, R., Collins, P. L., & Fearns, R. (2010) · Virology · doi:10.1016/j.virol.2010.07.006 · Cited by 70
Self-citationWaris, M. E., Tsou, C., Erdman, D. D., Day, D. B., & Anderson, L. J. (1997) · Journal of Virology · doi:10.1128/jvi.71.9.6935-6939.1997 · Cited by 70
Groskreutz, D. J., Babor, E. C., Monick, M. M., Varga, S. M., & Hunninghake, G. W. (2010) · Journal of Biological Chemistry · doi:10.1074/jbc.m109.077321 · Cited by 69
Olson, M. R., Hartwig, S. M., & Varga, S. M. (2008) · The Journal of Immunology · doi:10.4049/jimmunol.181.11.7958 · Cited by 68
A Double-Blind, Placebo-Controlled, Randomized Trial of Montelukast for Acute Bronchiolitis
Amirav, I., LUDER, A. S., Kruger, N., Borovitch, Y., Babai, I., Miron, D., Zuker, M., Tal, G., & Mandelberg, A. (2008) · PEDIATRICS · doi:10.1542/peds.2008-1744 · Cited by 68
Tang, R. S., Spaete, R. R., Thompson, M. W., MacPhail, M., Guzzetta, J. M., Ryan, P. C., Reisinger, K. S., Chandler, P. A., Hilty, M. D., WALKER, R. E., et al. (2008) · Vaccine · doi:10.1016/j.vaccine.2008.09.018 · Cited by 68
Nouën, C. L., Munir, S., Losq, S., Winter, C. C., McCarty, T. C., Stephany, D., Holmes, K. L., Bukreyev, A. A., Rabin, R. L., Collins, P. L., et al. (2009) · Virology · doi:10.1016/j.virol.2008.11.043 · Cited by 67
Self-citationde Swart, R. L., van den Hoogen, B. G., Kuiken, T., Herfst, S., van Amerongen, G., Yüksel, S., Sprong, L., & Osterhaus, A. D. M. E. (2007) · Vaccine · doi:10.1016/j.vaccine.2007.10.022 · Cited by 67
Schuurhof, A., Bont, L., Siezen, C. L. E., Hodemaekers, H. M., van Houwelingen, H. C., Kimman, T. G., Hoebee, B., Kimpen, J. L. L., & Janssen, R. (2010) · Pediatric Pulmonology · doi:10.1002/ppul.21229 · Cited by 67
Chaiwatpongsakorn, S., Epand, R. F., Collins, P. L., Epand, R. M., & Peeples, M. E. (2011) · Journal of Virology · doi:10.1128/jvi.01813-10 · Cited by 63
Self-citationMagro, M., Andreu, D., Gómez‐Puertas, P., Melero, J. A., & Palomo, C. (2010) · Journal of Virology · doi:10.1128/jvi.00447-10 · Cited by 59
Self-citationVallbracht, S., Unsoeld, H., & Ehl, S. R. (2006) · European Journal of Immunology · doi:10.1002/eji.200535642 · Cited by 58
Lagos, R., DeVincenzo, J. P., Muñoz, A., Hultquist, M., Suzich, J., Connor, E. M., & Losonsky, G. A. (2009) · The Pediatric Infectious Disease Journal · doi:10.1097/inf.0b013e3181a165e4 · Cited by 57
Boonyaratanakornkit, J. B., Bartlett, E. J., Schomacker, H., Surman, S. R., Akira, S., Bae, Y., Collins, P. L., Murphy, B. R., & Schmidt, A. (2010) · Journal of Virology · doi:10.1128/jvi.01297-10 · Cited by 55
Self-citationJones, B. G., Zhan, X., Mishin, V. P., Slobod, K. S., Surman, S. L., Russell, C. J., Portner, A., & Hurwitz, J. L. (2009) · Vaccine · doi:10.1016/j.vaccine.2009.01.041 · Cited by 54
Graham, B. S., Davis, T. H., Tang, Y., & Gruber, W. C. (1993) · Pediatric Research · doi:10.1203/00006450-199308000-00013 · Cited by 52
Review of palivizumab in the prophylaxis of respiratory syncytial virus (RSV) in high-risk infants
Mejías, A., & Ramilo (2008) · Biologics · doi:10.2147/btt.s3104 · Cited by 52
de Waal, L., Power, U. F., Yüksel, S., van Amerongen, G., Nguyen, T. N., Niesters, H. G. M., de Swart, R. L., & Osterhaus, A. D. M. E. (2003) · Vaccine · doi:10.1016/j.vaccine.2003.10.008 · Cited by 50
Toll‐like receptor 4 Asp299Gly polymorphism in respiratory syncytial virus epidemics
Löfgren, J., Marttila, R. H., Renko, M., Rämet, M., & Hallman, M. (2010) · Pediatric Pulmonology · doi:10.1002/ppul.21248 · Cited by 49
Heidema, J., Rossen, J. W. A., Lukens, M. V., Ketel, M. S., Scheltens, E., Kranendonk, M. E. G., van Maren, W. W. C., van Loon, A. M., Otten, H. G., Kimpen, J. L. L., et al. (2008) · The Journal of Immunology · doi:10.4049/jimmunol.181.8.5551 · Cited by 49
Lee, F. E.-H., Walsh, E. E., Falsey, A. R., Lumb, M. E., Okam, N. V., Liu, N., Divekar, A., Hall, C. B., & Mosmann, T. R. (2007) · The Journal of Infectious Diseases · doi:10.1086/518249 · Cited by 47
Snow, A. B., Dayyat, E. A., Montgomery‐Downs, H. E., Kheirandish‐Gozal, L., & Gozal, D. (2009) · Pediatric Pulmonology · doi:10.1002/ppul.21109 · Cited by 47
Nouën, C. L., Hillyer, P., Winter, C. C., McCarty, T. C., Rabin, R. L., Collins, P. L., & Buchholz, U. J. (2011) · PLoS Pathogens · doi:10.1371/journal.ppat.1002105 · Cited by 47
Self-citationWilliams, J. V., Weitkamp, J.-H., Blum, D. L., LaFleur, B., & Crowe, J. E. (2009) · Molecular Immunology · doi:10.1016/j.molimm.2009.08.024 · Cited by 47
Cytokines in severe respiratory syncytial virus bronchiolitis
Mobbs, K. J., Smyth, R. L., O'Hea, U., Ashby, D., Ritson, P. C., & Hart, C. A. (2002) · Pediatric Pulmonology · doi:10.1002/ppul.10101 · Cited by 43
In Vitro and In Vivo Fitness of Respiratory Syncytial Virus Monoclonal Antibody Escape Mutants
Zhao, X., Liu, E., Chen, F., & Sullender, W. M. (2006) · Journal of Virology · doi:10.1128/jvi.01387-06 · Cited by 42
Nouën, C. L., Hillyer, P., Munir, S., Winter, C. C., McCarty, T. C., Bukreyev, A. A., Collins, P. L., Rabin, R. L., & Buchholz, U. J. (2010) · PLoS ONE · doi:10.1371/journal.pone.0015017 · Cited by 40
Self-citationTwo novel fusion inhibitors of human respiratory syncytial virus
Lundin, A., Bergström, T. B., Bendrioua, L., Kann, N. C., Adamiak, B., & Trybala, E. (2010) · Antiviral Research · doi:10.1016/j.antiviral.2010.10.004 · Cited by 35
Rawling, J., Cano, O., Garcin, D., Kolakofsky, D., & Melero, J. A. (2011) · Journal of Virology · doi:10.1128/jvi.02065-10 · Cited by 34
Self-citationMcAuliffe, J. M., Surman, S. R., Newman, J. T., Riggs, J. M., Collins, P. L., Murphy, B. R., & Skiadopoulos, M. H. (2004) · Journal of Virology · doi:10.1128/jvi.78.4.2029-2036.2004 · Cited by 33
Self-citationElectron Cryomicroscopy Reveals Different F1+F2 Protein States in Intact Parainfluenza Virions
Ludwig, K., Schade, B., Böttcher, C., et al. (2008) · Journal of Virology · doi:10.1128/jvi.02154-07 · Cited by 32
de Alarcón, A., Walsh, E. E., Carper, H. T., Russa, J. B. L., Evans, B. A., Rakes, G. P., Platts‐Mills, T. A. E., & Heymann, P. W. (2001) · The Journal of Pediatrics · doi:10.1067/mpd.2001.111277 · Cited by 31
Luongo, C., Yang, L., Winter, C. C., Spann, K. M., Murphy, B. R., Collins, P. L., & Buchholz, U. J. (2009) · Vaccine · doi:10.1016/j.vaccine.2009.07.022 · Cited by 30
Self-citationMelendi, G. A., Hoffman, S. J., Karron, R. A., Irusta, P. M., Laham, F. R., Humbles, A. A., Schofield, B., Pan, C.-H., Rabold, R., Thumar, B., et al. (2006) · Journal of Virology · doi:10.1128/jvi.01783-06 · Cited by 28
Elliott, M. B., Chen, T., Terio, N. B., Chong, S.-Y., Abdullah, R., Luckay, A., Egan, M. A., Boutilier, L. A., Melville, K., Lerch, R. A., et al. (2007) · Vaccine · doi:10.1016/j.vaccine.2007.07.065 · Cited by 28
DiNapoli, J. M., Murphy, B. R., Collins, P. L., & Bukreyev, A. A. (2008) · Virology Journal · doi:10.1186/1743-422x-5-105 · Cited by 28
Self-citationStevens, W. W., Sun, J., Castillo, J., & Braciale, T. J. (2009) · Viral Immunology · doi:10.1089/vim.2009.0016 · Cited by 27
Motavizumab for the prevention of respiratory syncytial virus infection in infants
Gill, M. A., & Welliver, C. (2009) · Expert Opinion on Biological Therapy · doi:10.1517/14712590903287499 · Cited by 25
Immunogenic properties of RSV-B1 fusion (F) protein gene-encoding recombinant adenoviruses
Shao, H.-Y., Yu, S., Sia, C., Chen, Y., Chitra, E., Chen, I.-H., Venkatesan, N., Leng, C., Chong, P. C.-S., & Chow, Y. (2009) · Vaccine · doi:10.1016/j.vaccine.2009.07.004 · Cited by 24
Cited by
Viral Bronchiolitis in Children
Meissner, H. C. (2016) · New England Journal of Medicine · doi:10.1056/nejmra1413456 · Cited by 714
Respiratory Syncytial Virus: Infection, Detection, and New Options for Prevention and Treatment
Griffiths, C., Drews, S. J., & Marchant, D. J. (2017) · Clinical Microbiology Reviews · doi:10.1128/cmr.00010-16 · Cited by 586
Interferon-Lambda: A New Addition to an Old Family
Donnelly, R. P., & Kotenko, S. V. (2010) · Journal of Interferon & Cytokine Research · doi:10.1089/jir.2010.0078 · Cited by 420
Antunes, K. H., Fachi, J. L., de Paula, R., da Silva, E. F., Pral, L. P., dos Santos, A. Á., Dias, G. B. M., Vargas, J. E., Puga, R., Mayer, F. Q., et al. (2019) · Nature Communications · doi:10.1038/s41467-019-11152-6 · Cited by 385
A highly stable prefusion RSV F vaccine derived from structural analysis of the fusion mechanism
Krarup, A., Truan, D., Furmanova-Hollenstein, P., Bogaert, L., Bouchier, P., Bisschop, I. J. M., Widjojoatmodjo, M. N., Zahn, R., Schuitemaker, H., McLellan, J. S., et al. (2015) · Nature Communications · doi:10.1038/ncomms9143 · Cited by 383
Metadata
- Authors
- Collins, P. L., & Melero, J. A.
- Venue
- Virus Research
- Publisher
- Elsevier BV
- Published
- 2011-12
- Volume
- 162
- Issue
- 1-2
- Pages
- 80-99
- ISSN
- 0168-1702 (ISSN-L)
- OpenAlex
- W1989959574
- Cited by
- 455
- References
- 264
- FWCI
- 26.37
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.